Fibronectin-binding peptides. I. Isolation and characterization of two unique fibronectin-binding peptides from gelatin

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 45, Issue 3, 1998, Pages 275-284

  Gao, Xiaoyan ^a   Groves, Michael J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Binding affinity; Fibronectin binding peptide; Gelatin

Indexed keywords

FIBRONECTIN;

AFFINITY CHROMATOGRAPHY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; DRUG DESIGN; METASTASIS; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; GELATIN; HUMANS; HYDROLYSIS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; SPECTROPHOTOMETRY, ULTRAVIOLET; TRYPSIN;

EID: 0032077539     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(98)00010-1     Document Type: Article

References (47)

1. [1] L. Weiss, P.M. Ward, Cell detachment and metastasis, Cancer Metastas. Rev. 2 (1983) 111.
2. [2] L. Weiss, E. Mayhew, D. Glaves Rapp, J.C. Holmes, Metastatic inefficiency in mice bearing B16 melanomas, Br. J. Cancer 45 (1982) 44.
3. [3] J.B. McCarthy, M.L. Basara, S.L. Palm, D.F. Sas, L.T. Furcht, The role of cell adhesion proteins - laminin and fibronectin - in the movement of malignant and metastatic cells, Cancer Metastas. Rev. 4 (1985) 125.
4. [4] V.P. Terranova, E.S. Hujanen, G.R. Martin, Basement membrane and the invasive activity of metastatic tumor cells, J. Natl. Cancer Inst. 77 (1986) 311.
5. [5] J. Labat-Robert, P. Birembaut, L. Robert, J.J. Adnet, Modification of fibronectin distribution pattern in solid human tumors, Diagn. Histopathol. 4 (1981) 299.
6. [6] P. Birembaut, Y. Caron, J.J. Adnet, J.M. Foidart, Usefulness of basement membrane markers in tumoral pathology, J. Pathol. 145 (1985) 283.
7. [7] J.T. Rutka, C.A. Myatt, J.R. Giblin, R.L. Davis, M.L. Rosenblum, Distribution of extracellular matrix proteins in primary human brain tumours: an immunohistochemical analysis, Can. J. Neurol. Sci. 14 (1987) 25.
8. [8] N. Kochi, E. Tani, T. Morimura, T. Itagaki, Immunohistochemical study of fibronectin in human glioma and meningioma, Acta Neuropathol. 59 (1983) 119.
9. [9] S. Stenman, A. Vaheri, Fibronectin in human solid tumors, Int. J. Cancer 27 (1981) 427.
10. [10] S.K. Akiyama, K. Nagata, K.M. Yamada, Cell surface receptors for extracellular matrix components, Biochim. Biophys. Acta 1031 (1990) 91-110.
11. [11] M.J. Humphries, The molecular basis and specificity of integrin-ligand interactions, J. Cell Sci. 97 (1990) 585-592.
12. [12] K.M. Yamada, Adhesive recognition sequences, J. Biol. Chem. 266 (1991) 12809-12812.
13. [13] R.O. Hynes, Integrins: versatility, modulation and signaling in cell adhesion, Cell 69 (1992) 11-25.
14. [14] M.J. Humphries, K. Olden, K.M. Yamada, A synthetic peptide from fibronectin inhibitors experimental metastasis of murine melanoma cells, Science 233 (1986) 467-470.
15. [15] P. Savagner, B.A. Imholf, K.M. Yamada, Homing of hemopoietic precursor cells to the embryonic thymus: Characterization of an invasive mechanism induced by chemotactic peptides, J. Cell Biol. 103 (1986) 2715-2727.
16. [16] M.J. Humphries, Fibronectin and cancer: rationales for the use of antiadhesives in cancer treatment, Cancer Biol. 4 (1993) 293-299.
17. [17] D.F. Mosher, Fibronectin, Prog. Hemostasis Thromb. 5 (1980) 111-151.
18. [18] H. Forastieri, K.C. Ingham, Fluid-phase interaction between human plasma fibronectin and gelatin determined by fluorescence polarization assay, Arch. Biochem. Biophys. 227 (1983) 358-366.
19. [19] K.C. Ingham, S.A. Brew, B.S. Isaacs, Interaction of fibronectin and its gelatin-binding domains with fluorescent-labeled chains of type I collagen, J. Biol. Chem. 263 (10) (1988) 4624-4628.
20. [20] A. Garcia-Pardo, L.I. Gold, Further characterization of the binding of fibronectin to gelatin reveals the presence of different binding interactions, Arch. Biochem. Biophys. 304 (1) (1993) 181-188.
21. [21] K. Nakamura, S. Kashiwagi, K. Takeo, Characterization of the interaction between human plasma fibronectin and collagen by means of affinity electrophoresis, J. Chromatog. 597 (1992) 351-356.
22. [22] Y. Lou, W.P. Olson, X.X. Tian, M.E. Klegerman, M.J. Groves, Interaction between fibronectin-bearing surfaces and Bacillus Calmette-Guérin (BCG) or gelatin microparticles, J. Pharm. Pharmacol. 47 (1995) 177-181.
23. [23] K. Nagata, M.J. Humphries, K. Olden, K.M. Yamada, Collagen can modulate cell interactions with fibronectin, J. Cell Biol. 101 (1985) 386-394.
24. [24] D.L. Heene, D. Zekorn, H.G. Lasch, Gelatin plasma volume expanders: chemistry, biological activities and clinical experiences, in: Proc. 11th Congr. Int. Soc. Blood Transf., Sydney, 1966, Bibl. No. 29, Part 3, Karger, New York, 1968, pp. 907-913.
25. [25] H.H. Schöne, Chemistry and physicochemical characterization of gelatin plasma substitutes. Modified gelatin as plasma substitutes, Biol. Haematol. 33 (1969) 78-90.
26. [26] D. Zekorn, Intravascular retention, dispersal, excretion and breakdown of gelatin plasma substitutes. Modified gelatin as plasma substitutes, Biol. Haematol. 33 (1969) 131-140.
27. [27] B. Brodin, F. Hesselvik, H. von Schenck, Decrease of plasma fibronectin concentration following infusion of a gelatin-based plasma substitute in man, Scand. J. Clin. Lab. Invest. 44 (1984) 529-533.
28. [28] J.M. Saddler, P.J. Horsey, The new generation gelatins: a review of their history, manufacture and properties, Anaesthesia 42 (1987) 998-1004.
29. [29] J.M. Vedrinne, J.P. Hoen, D. Bussery, C. Veyssere, M. Richard, J. Motin, Plasma fibronectin and complement following infusion of colloidal solutions after spinal anaesthesia, Intens. Care Med. 17 (1991) 83-86.
30. 125I-DLT gelatin after burn injury: a model of soluble collagenous debris that interacts with plasma fibronectin, J. Leukocyte Biol. 54 (1993) 56-64.
31. [31] R.T. Jones, Gelatin: structure and manufacture, in: K. Ridgeway (Ed.), Hard Gelatin, Development and Technology, Pharma Press, London, 1987, p. 15.
32. [32] E. Tillet, K. Mann, R. Nischt, T.C. Pan, Recombinant analysis of human alpha 1 (XVI) collagen. Evidence for processing of the N-terminal globular domain, Eur. J. Biochem. 228 (1) (1995) 160-168.
33. [33] P.P. Fietzek, K. Kühn, The primary structure of collagen, Int. Rev. Connect. Tissue Res. 7 (1976) 1-60.
34. [34] K. Katayama, J. Armendariz-Borunda, R. Raghow, A.H. Kang, J.M. Seyer, A pentapeptide from type I procollagen promotes extracellular matrix production, J. Biol. Chem. 268 (14) (1983) 9941-9944.
35. [35] D.J.S. Hulmes, A. Miller, D.A.D. Parry, K.A. Piez, J. Woodhead-Galloway, Analysis of primary structure of collagen for origins of molecular packing, J. Mol. Biol. 79 (1973) 137-148.
36. [36] R.W. Glanville, D. Breitkreutz, M. Meitinger, P.P. Fietzek, Completion of the amino acid sequence of the α1 chain from type I calf skin collagen, Biochem. J. 215 (1983) 183-189.
37. [37] J. Rauterberg, P.P. Fietzek, F. Rexrodt, U. Becker, M. Stark, K. Kühn, The amino acid sequence of the carboxyterminal nonhelical cross link region of the α1 chain of calf skin collagen, FEBS Lett. 21 (1972) 75-79.
38. [38] J. Rauterberg, The C-terminal non-helical portion of the collagen molecule, Clin. Orthop. 97 (1973) 196-212.
39. [39] T. Vartio, Fibronectin: multiple interactions assigned to structural domains, Med. Biol. 61 (1983) 283-295.
40. [40] W. Dessau, B.C. Adelmann, R. Timp, Identification of the sites in collagen α-chains that bind serum anti-gelatin factor (cold-insoluble globulin), Biochem. J. 169 (1978) 55-59.
41. [41] B.C. Adelmann-Grill, Independence of reciprocal attachment sites on denatured collagen and fibronectin from antigenic sites, and binding of gelatin-based plasma substitute to plasma fibronectin, Collagen Rel. Res. 1 (1981) 367-375.
42. [42] E. Engvall, Quantitative enzyme immunoassay (ELISA) in microbiology, Med. Biol. 55 (1977) 193.
43. [43] B.K. van Weemen, A.H.W.M. Schuurs, Immunoassay using antigen-enzyme conjugates, FEBS Lett. 15 (1971) 232.
44. [44] L. Belanger, Alternative approaches to enzyme immunoassay, Scand. J. Immunol. 8(suppl. 7) (1978) 33-45.
45. [45] P. Damas, A. Adam, J. Buret, C.L. Renard, M. Lamy, B. Foidart, P.H. Mahieu, In-vivo studies on Haemaccel-fibronectin interaction in man, Eur. J. Cancer Invest. 17 (1987) 166-173.
46. [46] P.A. Vincent, P.J. Del Vecchio, T.M. Saba, Release of fibronectin fragments from endothelial cell monolayers exposed to activated leukocytes: relationship to plasma fibronectin levels after particle infusion, Exp. Mol. Pathol. 48 (1988) 403-418.
47. [47] I. Daudi, P.W. Gudewicz, T.M. Saba, E. Cho, M.B. Frewin, Leukocyte elastase-independent proteolysis of gelatin-bound fibronectin by inflammatory macrophages, Inflammation 15 (60) (1991) 481-495.